Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?

Lynch, Holly Fernandez; Caplan, Arthur; Furlong, Patricia; Bateman-House, Alison

Lynch, Holly Fernandez; Caplan, Arthur; Furlong, Patricia; Bateman-House, Alison.

Afiliação

Lynch HF; University of Pennsylvania.
Caplan A; NYU Langone Health.
Furlong P; Parent Project Muscular Dystrophy.
Bateman-House A; NYU Langone Health.

Am J Bioeth ; 21(12): 4-19, 2021 12.

Article em En | MEDLINE | ID: mdl-34665689

Assuntos

COVID-19; Pandemias; Desenvolvimento de Medicamentos; Humanos; SARS-CoV-2

Palavras-chave

COVID-19; Operation Warp Speed; clinical research; emergency use authorization; expanded access; pandemic response

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Am J Bioeth Assunto da revista: ETICA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google